ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,465.66
0.12%
Dow Jones
40,571.06
-0.05%
US Dollar vs MXN
18.656
1.07%
Brent Oil
79.055
-1.89%
Bitcoin
67,221.50
-0.85%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. ETFs
  4. Estados Unidos
  5. NYSE

  6. Thor Low Volatility ETF (THLV) Cotización

Thor Low Volatility ETF

Thor Low Volatility ETF (THLV)

Thor Low Volatility ETF
27.3501
0.1187
( 0.44% )
Actualizado: 13:02:58
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
27.3501
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
964
27.26 Rango del Día 27.3501
23.77 Rango de 52 semanas 27.6884
Precio Anterior
27.2314
Precio de Apertura
27.30
Hora
7
@
27.3601
Última hora de negociación
12:22:36
Volumen promedio (3 m)
6,607
Volumen financiero
US$ 26,327
Precio Promedio Ponderado
27.31

THLV Últimas noticias

Más noticias

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire PLYMOUTH MEETING, Pa., July...

25 Julio 2024
PR Newswire (US)

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 25, 2024 PLYMOUTH MEETING, Pa., July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO...

25 Julio 2024
PR Newswire (US)

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire PLYMOUTH MEETING, Pa., July 11, 2024 Award recognizes the...

11 Julio 2024
PR Newswire (US)

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR Newswire PLYMOUTH MEETING, Pa., July 2, 2024 Mr. Egge brings over 25 years of biopharmaceutical experience building...

02 Julio 2024
PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., July 1, 2024 PLYMOUTH MEETING, Pa., July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology...

01 Julio 2024
PR Newswire (US)

INOVIO Added to Russell 2000® Index Effective July 1, 2024

INOVIO Added to Russell 2000® Index Effective July 1, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 1, 2024 PLYMOUTH MEETING, Pa., July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a...

01 Julio 2024
PR Newswire (US)

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. PR Newswire PLYMOUTH MEETING, Pa., June 4, 2024 PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a...

04 Junio 2024
PR Newswire (US)

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., May 31, 2024 PLYMOUTH MEETING, Pa., May 31, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...

31 Mayo 2024
PR Newswire (US)

Form 8-K - Current report

28 Mayo 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

22 Mayo 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.01070.039137654813227.339427.4326.9771755227.17540003SP
40.48811.8170649988826.86227.688426.588652327.1104273SP
120.83013.1300904977426.5227.688426.44660726.95122319SP
262.09018.2743467933525.2627.688425.19853426.55849674SP
521.25014.7896551724126.127.688423.771815625.13405275SP
1561.766.8776597199725.590127.688423.382722324.96942466SP
2601.766.8776597199725.590127.688423.382722324.96942466SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TWOU2U Inc
US$ 3.1301
(150.41%)
116.33M
LIPOLipella Pharmaceuticals Inc
US$ 0.873599
(116.18%)
183.97M
YIBOPlanet Image International Ltd
US$ 4.65
(59.52%)
27.89M
NIPGNIP Group Inc
 14.25
(57.98%)
5.91M
TIVCTivic Health Systems Inc
US$ 0.6299
(39.36%)
85.79M
CGTXCognition Therapeutics Inc
US$ 1.4666
(-38.12%)
22.27M
CEROCERo Therapeutics Holdings Inc
US$ 0.18
(-29.69%)
7.09M
LUXHLuxUrban Hotels Inc
US$ 0.1457
(-23.72%)
5.68M
VTVTvTv Therapeutics Inc
US$ 16.19
(-23.63%)
126.32k
NXTTNext Technology Holding Inc
US$ 1.18
(-22.88%)
375.76k
LIPOLipella Pharmaceuticals Inc
US$ 0.8701
(115.32%)
183.97M
NVDANVIDIA Corporation
US$ 112.45
(-0.54%)
171.26M
SQQQProShares UltraPro Short QQQ
US$ 8.99
(-1.21%)
120.71M
TWOU2U Inc
US$ 3.145
(151.60%)
116.33M
NLSPNLS Pharmaceutics Ltd
US$ 0.257
(35.26%)
112.02M

Discusión

Ver feed completo
powerwalker powerwalker 5 minutos hace
Plus, bb, its volume is over 3.8 million. Its short position I think is 36%+. Maybe, the shorts are confused as to which company reported a 39% reduction in decline. ;)
AVXL
timberwolf7 timberwolf7 5 minutos hace
IF you have been around the market long enough, and went for
NOVEL ideas when they were first announced, chances are you
COULD have made money if you were fortunate enough to sell
the initial hype.
Far too often there is a rally as folks pile in, then the long trail
SHMP
AugustaFriends AugustaFriends 6 minutos hace
$RNLX boom at
50
RNLX
gorbec1 gorbec1 6 minutos hace
Just waiting on things bens hiding
MCIC
capgain capgain 6 minutos hace
FJB :)
Royal Dude Royal Dude 6 minutos hace
Mother Bond $125,157,168,784
JPMORGAN CHASE & CO.
Debt Securities
Warrants
Units
Purchase Contracts
Guarantees
JPMORGAN CHASE FINANCIAL COMPANY LLC
Debt Securities
Warrants
We, JPMorgan Chase & Co., may from time to time offer and
COOP
BeachBum BeachBum 6 minutos hace
Let the pumping begin! AHRO
AHRO
$PennyMover $PennyMover 6 minutos hace
Folks think this is going to no bid.
I guess cuz they don't post any news or updates.

So far, I don't see that happening & financials keep posting on time.
BLDV
trademax42 trademax42 6 minutos hace
The .0036s have thinned out, and the .0037s are imminent. imo
HIRU
stockstobuy stockstobuy 6 minutos hace
Here is abig red flag!
NSAV
iclight iclight 6 minutos hace
They probably died of old age.
NWBO
capgain capgain 6 minutos hace
Very true, most of us are just along for the ride. Have a good one yourself.
Jepape Jepape 7 minutos hace
I was watching a movie called The Cure last night where they were trying to get into human trials but the toxicology testing was going to take 3 months and they could not wait. So the main scientist took paid subjects down to sub level 6, tied them down, and injected them. Let’s hope Jim can get u
GSTC
nowwhat2 nowwhat2 7 minutos hace
The 2 freaking levels I've been joking SO much about ;


https://investorshub.advfn.com/uimage/uploads/2024/7/29/[ihdkbtc_777_29_15d_2021_66666_plain.jpg



https://investorshub.advfn.com/uimage/uploads/2024/7/29/owcurbtc_777_29_capt_1040am_66666_7.j
BTCUSD
WhAtEvA1 WhAtEvA1 7 minutos hace
I doubt he's trying to calm anyone. On the contrary, he's doing what everyone is doing.....taking the opportunity to add. No need to read too much into it.
RDGL
DJ Ponder DJ Ponder 7 minutos hace
Career coman ceo thomas scozzafava has run this dog into the ground.
10 billion out , triple zero one, yet another reverse split on the horizon.
What other RED FLAGS ARE NEEDED?


https://investorshub.advfn.com/uimage/uploads/2017/2/3/salidIMG_0876.JPG
KEGS
getmoreshares getmoreshares 7 minutos hace
expect updates very soon-- late week or early next- see the sticky video
NBRI
meitze meitze 7 minutos hace
Yes, it does and with my track record they'll probably release a PR tomorrow.
XERI
1plus1 1plus1 7 minutos hace
THE 8K IS FACTOR AT .015+
HIRU
Biggiee Biggiee 7 minutos hace
Feels like it could be a buy out. Market cap isn’t even a billy, and we are talking about NARCAN! Any guesses above these prices seems like a good bet
EBS
Hi_Lo Hi_Lo 8 minutos hace
https://www.securitieslawyer101.com/2023/shell-hijacker-mark-miller-sentenced-to-one-year-in-prison/

Court documents show that Capitol Capital Corporation received several big chunks of stock in IGEX, then transferred the shares to Tiger Trout Capital LLC, a Puerto Rican entity contro
CNNA IGEX MEDH
iclight iclight 8 minutos hace
Shot on Betamax.
NWBO
Hoskuld Hoskuld 8 minutos hace
Since you think the timeline for an MAA is different than my understanding then I cannot resolve that for you.
AVXL
CrimsonNightRider CrimsonNightRider 8 minutos hace
How do we combat naked shorts?

https://investorshub.advfn.com/uimage/uploads/2024/6/17/bsdxk32CB05E3-B6DD-45EF-98BD-9A8A0426BBCC.jpeg
ASTA
Carjockey2 Carjockey2 8 minutos hace
I reposted this on Twitter and MM gave it a like..lol

https://x.com/cocomoco1234567/status/1817982223892861121?t=GobpV_eJTSYPfPQzo4Uj3A&s=19
HIRU

Su Consulta Reciente

NYSE
THLV
Thor Low Volatility ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados